top of page
Invokamet is made up of two medications, canagliflozin and metformin hydrochloride. It's used with diet and exercise to treat adults with type 2 diabetes. Canagliflozin is used to decrease the risk of serious cardiovascular events in adults with type 2 diabetes and heart disease and the risk of end-stage kidney disease, doubling serum creatinine levels, death caused by cardiovascular reasons, and hospitalization for adults with type 2 diabetes, heart failure, and diabetic kidney disease with the presence of albumin in the urine. Invokamet should not be used to treat adults with type 1 diabetes as this may increase their risk for a serious condition called diabetic ketoacidosis. Fact Table Formula C24H25FO5S License US DailyMed, EU EMA Bioavailability 65% Legal status Rx-Only Chemical Name Canagliflozin/metformin Elimination half-life 10–13 hours Dosage (Strength) 50/1000mg, 50/500mg, 150/1000mg, 150/500mg Pregnancy Not recommended Brands Invokamet Protein binding 99% PubChem CID 24812758 MedlinePlus a613033 ChEBI 73274 ATC code A10BK02 DrugBank DB08907 KEGG D09592 Routes of administration By mouth

Invokamet (Canagliflozin/metformin)

  • Follow your doctor's instructions and read the information that comes with your Invokamet prescription. Don't hesitate to reach out to your doctor or pharmacist with any questions or concerns you have. Invokamet oral tablets are available in the following strengths: Canagliflozin 50 mg and metformin HCl 500 mg, Canagliflozin 50 mg and metformin HCl 1,000 mg, Canagliflozin 150 mg and metformin HCl 500 mg, Canagliflozin 150 mg and metformin HCl 1,000 mg The recommended starting dose is Invokamet (canagliflozin 50 mg and metformin 500 mg) by mouth two times a day with meals. The dose may be adjusted based on kidney function and response to the medication.
bottom of page